In a groundbreaking study, Stanford researchers reveal that heart attack deaths have plummeted by 89% since 1970, but deaths from other heart conditions like heart failure and irregular heartbeats are surging. Discover the alarming new trends in heart disease mortality.
Explore groundbreaking health trends from exosome treatments and HIV prevention injections to new obesity pills and brain implants. What do experts really think? Dive into the latest in health innovation and skepticism.
A groundbreaking study shows that bariatric surgery leads to five times more weight loss than GLP-1 drugs like semaglutide. Discover why surgery remains the gold standard in obesity treatment.
Appendix cancer diagnoses are on the rise, particularly among younger adults. Experts are puzzled by this trend and urge awareness of vague symptoms that could indicate this rare disease. Learn more about the potential causes and prevention strategies.
A new regulator confirmation links Ozempic to a rare eye condition, NAION, affecting diabetes patients. This revelation raises concerns about potential blindness risks associated with semaglutide. Discover the implications for users.
Research reveals that over 15 million people in the US, UK, Germany, and France are unaware they have metabolic dysfunction-associated steatotic liver disease, a condition linked to severe health risks. Experts call for increased screenings and diagnosis rates.
A groundbreaking study shows that GLP-1 diabetes drugs may reduce the risk of obesity-related cancers by 7% compared to DPP-4 inhibitors, particularly in women. Discover the implications for diabetes treatment!
A new report reveals alarming trends in childhood health, linking rising chronic diseases to ultra-processed foods and a lack of physical activity. Are we failing our children?
A new study reveals that a healthier diet can lead to later onset of menarche, potentially reducing the risk of chronic diseases in women. Discover how what you eat impacts your menstrual health.
Recent clinical trials show that GLP-1 weight loss medications like Zepbound are more effective for women than men, prompting researchers to explore the biological and societal reasons behind this phenomenon.
